Ontology highlight
ABSTRACT: Objective
To evaluate the role of CCAAT/enhancer-binding protein ? (C/EBP ? (C/EBP.Methods
Rats with OIR were exposed to alternating hypoxic and hyperopic conditions for 14 days. Then, the rats with OIR were assigned randomly to groups that received intravitreal injections of either shRNA lentiviral particles targeting C/EBP ? (C/EBP ? (C/EBP ? (C/EBP ? (C/EBP ? (C/EBP ? (C/EBP.Results
In OIR rats, the expression levels of C/EBP ? (C/EBP P < 0.01). The p-C/EBP ? (C/EBP ? (C/EBP ? (C/EBP ? (C/EBP ? (C/EBP P < 0.01). The p-C/EBP ? (C/EBP ? (C/EBP ? (C/EBP P < 0.01). The p-C/EBP.Conclusions
C/EBP ? shRNA inhibits RNV in OIR. A potential mechanism may be that the activity of C/EBP ? increases with its overexpression, which in turn aggravates the amount of the retinal vascular damage and promotes transcription of VEGF. C/EBP ? might be a new therapeutic target for preventing RNV.? (C/EBP ? (C/EBP ? (C/EBP.
SUBMITTER: Li T
PROVIDER: S-EPMC7085405 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
Li Tingting T Cai Xuan X Wang Xiangning X Zhang Xueyan X Zhang Hui H Xu Biwei B Li Shiwei S Hu Jianyan J Wu Qiang Q
Journal of diabetes research 20200309
<h4>Objective</h4>To evaluate the role of CCAAT/enhancer-binding protein <i>β</i> (C/EBP <i>β</i> (C/EBP.<h4>Methods</h4>Rats with OIR were exposed to alternating hypoxic and hyperopic conditions for 14 days. Then, the rats with OIR were assigned randomly to groups that received intravitreal injections of either shRNA lentiviral particles targeting C/EBP <i>β</i> (C/EBP <i>β</i> (C/EBP <i>β</i> (C/EBP <i>β</i> (C/EBP <i>β</i> (C/EBP <i>β</i> (C/EBP.<h4>Results</h4>In OIR rats, the expression lev ...[more]